Mindray Medical Intl (MR)

Add to Watchlists
Create an Alert
27.24 +0.01  +0.04% NYSE Feb 5, 20:00 Delayed 2m USD

Mindray Medical Intl Research and Development Expense (Quarterly):

37.09M for Sept. 30, 2015
View 4,000+ financial data types
View Full Chart

Mindray Medical Intl Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Mindray Medical Intl Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 2004. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2015 37.09M
June 30, 2015 36.40M
March 31, 2015 34.49M
Dec. 31, 2014 48.78M
Sept. 30, 2014 34.35M
June 30, 2014 33.72M
March 31, 2014 30.14M
Dec. 31, 2013 40.99M
Sept. 30, 2013 31.57M
June 30, 2013 28.57M
March 31, 2013 26.33M
Dec. 31, 2012 32.93M
Sept. 30, 2012 23.22M
June 30, 2012 23.88M
March 31, 2012 24.28M
Dec. 31, 2011 25.59M
Sept. 30, 2011 19.34M
June 30, 2011 18.50M
March 31, 2011 18.59M
Dec. 31, 2010 16.76M
Sept. 30, 2010 14.80M
June 30, 2010 14.32M
March 31, 2010 14.44M
Dec. 31, 2009 14.75M
Sept. 30, 2009 14.17M
June 30, 2009 14.72M
March 31, 2009 14.74M
Dec. 31, 2008 23.18M
Sept. 30, 2008 14.62M
June 30, 2008 12.32M
March 31, 2008 8.422M
Dec. 31, 2007 9.855M
Sept. 30, 2007 7.568M
June 30, 2007 6.407M
March 31, 2007 5.343M
Dec. 31, 2006 6.057M
Sept. 30, 2006 4.618M
June 30, 2006 4.307M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


MR Research and Development Expense (Quarterly) Benchmarks

Cantel Medical 3.765M
The Cooper Companies 18.36M
Haemonetics 10.94M

MR Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 18.50M Jun 2011
Maximum 48.78M Dec 2014
Average 29.94M

MR Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("MR", "r_and_d_expense")
  • Last 5 data points: =YCS("MR", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.